| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 23 |
| 1 | ABATACEPT | 22 |
| 2 | ADALIMUMAB | 22 |
| 3 | ANAKINRA | 22 |
| 4 | METHOTREXATE | 22 |
| 5 | METHOTREXATE SODIUM | 22 |
| 6 | TOCILIZUMAB | 22 |
| 7 | HYDROXYCHLOROQUINE | 20 |
| 8 | LEFLUNOMIDE | 20 |
| 9 | TOFACITINIB | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIDOCAINE HCL AND EPINEPHRINE | 1 | 0.1429 |
| 1 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 2 | ANAKINRA | 22 | 0.0013 |
| 3 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| 4 | TOCILIZUMAB | 22 | 0.0002 |
| 5 | LEFLUNOMIDE | 20 | 0.0002 |
| 6 | ABATACEPT | 22 | 0.0002 |
| 7 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 1 | 0.0001 |
| 8 | PROPOFOL | 4 | 0.0001 |
| 9 | BUPIVACAINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 22 | 0.0013 |
| 1 | Antirheumatic Agent [EPC] | 20 | 0.0002 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 22 | 0.0002 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 22 | 0.0002 |
| 4 | General Anesthetic [EPC] | 4 | 0.0001 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 22 | 0.0000 |
| 7 | Aminosalicylate [EPC] | 4 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 23 | 0.0000 |